ADHD drugs Flashcards
amphetamines moa
releases DA and NE
Atomoxetine moa
selective NE reuptake inhibitor centrally and peripherally
clonidine moa
believed due to regulation of NE release from locus ceruleus via alpha-2 agonism
guanfacine moa
post-synaptic alpha-2-receptor agonist effects in the pre-frontal cortex
haloperidol moa
blocks post synaptic D2 receptors
amphetamine interaction with acetazolamide or bicarb
alkaline urine favors repute of drug in renal tubules; increases serum drug levels
amphetamine interaction with ammonium chloride
acidic urine favors renal eliminaiton; decreases serum drug levels
chlorpromazine, haloperidol interactions with amphetamine
DA receptor blockers diminish effects of amphetamines
dextromethorphan effects when used with amphetamine
increased impaired judgement and erratic euphoria
effects of digoxin when used with amphetamines
increased pro-arrhythmogenic effect
MAOIs when used with amphetamines
increased serum drug levels and toxicity
amphetamine, methylphenidate, and atomoxetine metabolism
CYP 2D6 induction or inhibition
amphetamine adverse effects
common: abdominal pain, headache, insomnia, loss of appetite
less common: anxiety, emotional lability, nervousness, tachycardia, weight loss
atomoxetine and methylphenidate interactions with albuterol
accentuates CV adverse effects
atomoxetine interactions with epinephrine
further increase in BP